Search results
California joining with New Jersey company to make generic opioid overdose reversal drug
KABC 7 Los Angeles· 2 hours agoCalifornia will soon begin selling its own generic version of Narcan - the drug that can save...
Lilly Raises 2024 Guidance as Zepbound Flies Off Shelves
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- Eli Lilly & Co.’s shares jumped after it raised its annual guidance on soaring demand...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 56 minutes agoEli Lilly stock surged within striking distance of a breakout in late April after the company...
Eli Lilly Surges On Guidance Boost After Weight-Loss Drug Obliterates Sales Views
Investor's Business Daily· 2 hours agoBolstered Weight-Loss Drug Production Notably, Eli Lilly raised its full-year sales outlook by $2...
Weight loss drugs are so hot that Eli Lilly is expecting $2 billion more in sales this year
Quartz· 22 minutes ago“Lilly’s first quarter performance reflects solid year-over-year revenue growth with...Zepbound,” said Eli Lilly CEO David A. Ricks in a press release. The company’s revenue ...
These Are the Drugs America Is Running Short On
247wallst.com· 24 hours agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters via Yahoo Finance· 5 hours ago(Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 2 hours agoIn her tenure the agency so far has challenged two major pharmaceutical mergers, sued a...
Eli Lilly lifts profit view on diabetes and weight-loss drug strength
WSAU Wausau· 5 hours ago(Reuters) -Eli Lilly on Tuesday raised its full-year profit forecast, betting on surging demand for...
Why Eli Lilly Stock Is Jumping Today
Motley Fool via Yahoo Finance· 45 minutes agoLilly did both in its Q1 update. Lilly increased its 2024 full-year revenue outlook to a range of $42.4 billion to $43.6 billion, $2 billion higher than...
